{
    "id": 3114,
    "name": "serous cystadenocarcinoma",
    "source": "DOID",
    "definition": "A cystadenocarcinoma that derives_from epithelial cells originating in glandular tissue forming serous lesions. [url:http\\://ukpmc.ac.uk/abstract/MED/16025006]",
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:3114",
    "evidence": [
        
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT02834013",
            "title": "Nivolumab and Ipilimumab in Treating Patients With Rare Tumors",
            "phase": "Phase 0",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 1627,
                    "therapyName": "Ipilimumab + Nivolumab",
                    "synonyms": null
                }
            ]
        }
    ]
}